Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-19

Clinical Trial Update: Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients [NA]

View source ↗

Summary

A completed clinical trial investigating the integration of insulin delivery with glucose sensing in subcutaneous tissue for treating Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Graz | Conditions: Type 1 Diabetes | NA | Status: COMPLETED